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ABSTRACT 
The Impacts of Arterial Occlusion, Sex, and Exercise on Arteriogenesis and Functional Vasodilation 
Megan Tze-Mei Chu 
 
The most frequent clinical presentation of peripheral arterial occlusive disease (PAOD) is intermittent 
claudication, which may be caused by impaired vasodilation. Patients demonstrate both local and 
systemic impairments in vasodilation, but as the collateral circulation is the primary site of resistance to 
the ischemic zone, impaired collateral vasodilation would have the greatest potential to induce 
claudication. Collateral function following arterial occlusion is not well defined, but immature collaterals 
may demonstrate impaired vasodilation in animal models, although this is potentially improved with 
exercise training. Furthermore, as females exhibit poorer physical function with ischemia and less 
improvement with therapeutic exercise, there appears to be a sexually dimorphic response to PAOD, 
warranting a comparison in collateral vasodilation between sexes. In this study, the femoral artery was 
ligated to induce chronic ischemia in sedentary and exercise-trained mice, and at 7 or 28 days post-
surgery, the diameter of the gracilis collateral arteriole was measured at rest and after gracilis muscle 
contraction using intravital microscopy. No major sex differences were observed in any group. At day 7, 
both the resting and dilated diameters were increased, while vascular reactivity was minimal. By day 28, 
resting diameter decreased while maximal diameter was unchanged, causing an increase in functional 
vasodilation. Exercise training also improved vasodilation by decreasing collateral resting diameter. 
These results are consistent with reported trends in endothelium-dependent and smooth muscle-dependent 
vasodilation, which are impaired in immature vessels and improved with maturation and exercise, but the 
significance of the observed variations in resting diameter remains unclear. Large resting diameters at day 
7 could be due to a loss of sympathetic tone or the proliferative and non-contractile state of smooth 
muscle cells, while decreased resting diameters at day 28 could indicate that a smooth muscle contractile 
phenotype has been restored, or that the gracilis collateral is no longer the primary collateral. However, 
the further research is required to determine the functional relevance of collateral resting diameter and its 
importance in the ischemic limb circulation. 
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INTRODUCTION 
The most frequent clinical presentation of peripheral arterial occlusive disease (PAOD) is intermittent 
claudication, which is characterized by pain with exercise that is relieved at rest [1,2,3,4]. A common 
explanation for intermittent claudication and other complications arising from PAOD, such as chronic 
ulceration, is poor collateralization [3,4,5].  Because of this, there have been many attempts to define the 
mechanism of and develop therapies to stimulate collateral arteriogenesis, which is triggered by increased 
shear stress and aided by many pro-angiogenic and pro-inflammatory cytokines [6]. Potential therapies in 
this area include the delivery of growth factors, such as VEGF and FGF, which increase collateral-
dependent blood flow by increasing vascular remodeling following occlusion [7]. In addition to gene or 
protein therapies, cells can be transplanted to the ischemic or peri-ischemic zones [8], presumably to 
produce the cytokines and growth factors necessary for collateral enlargement, although these actions are 
not well-described [9]. In clinical studies, transplanting bone marrow-derived mononuclear cells or 
endothelial progenitor cells improved ankle-brachial index (ABI) [8,9]. However, poor collateralization as 
an explanation for PAOD pathophysiology does not take into account the disparity between ABI and 
performance [10]. Specifically, long-term supervised exercise training increases pain-free walking 
distance without increasing the ABI or number of arteries as measured by magnetic resonance 
angiography [11], suggesting that claudication and its resolution are due to processes other than 
collateralization.  
An alternative explanation for intermittent claudication in patients with peripheral atherosclerosis is 
impaired vasodilation in the resistance vessels [12]. Vasodilation is impaired in both the upper [13] and 
lower [14] extremities but also in the collateral circulation, highlighted by the correlation between 
exercise blood flow and flow reserve to the ischemic zone with disease severity [15]. Furthermore, 
vasoconstrictor administration for the treatment of headaches aggravates claudication symptoms in 
patients with PAOD [16,17], indicating that a restricted ability to increase blood flow contributes to 
symptomatic disease presentation. Because the collateral circulation is the primary site of vascular 
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resistance following arterial occlusion [18,19,20], impaired vasodilation of collaterals is most likely to 
have greatest potential impact on intermittent claudication. Indeed, decreased vasodilatory reserve in 
myocardium perfused by collateral flow correlated with more prevalent ischemic symptoms during 
exercise [21], highlighting the contribution of impaired collateral vasodilation to the pathophysiology of 
ischemic disease.  
As arteriogenesis occurs with collateral recruitment following arterial occlusion, it is possible that the 
remodeling process may negatively influence reactivity in the collateral vessels during development. 
However, because reports regarding endothelium-dependent and smooth muscle-dependent collateral 
vasodilation are somewhat inconsistent, it is unclear which component of arteriogenesis is the cause of 
this impaired reactivity. In animal models, vasodilation to endothelium-dependent agents is impaired in 
immature collaterals [22,23,24,25,26] but is either completely restored [25] or still noticeably impaired 
[26] after maturation. This is potentially due to endothelial dysfunction induced as a result of either a 
chronic increase in collateral flow [27] or inflammatory conditions during remodeling [28]. However, as 
endothelium-dependent mechanisms of vasodilation are contingent upon smooth muscle cell function, 
these observations do not necessarily implicate the endothelium as the cause of impairment. For example, 
both endothelium-dependent and endothelium-independent dilation responses are attenuated in immature 
feed arteries and restored after maturation [29], indicating smooth muscle dysfunction. Although 
remodeling processes differ between feed arteries and collaterals, endothelium-independent vasodilation 
is also impaired in collateral vessels throughout maturation [26,30,31]. In collaterals, smooth muscle 
dysfunction could be the result of the change in smooth muscle cell phenotype from contractile to 
synthetic that occurs during proliferation [32,33]. The structural increase in vessel size is nearly complete 
[34] in immature collaterals, but smooth muscle cells are actively proliferating [35], whereas in mature 
collaterals, smooth muscle proliferation has ceased [35] and structural enlargement is maintained [34]. 
Because both endothelium-dependent and smooth muscle-dependent reactivity are impaired during 
collateral development, smooth muscle proliferation and differentiation to a synthetic phenotype during 
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arteriogenesis is likely the cause of vasodilatory impairment and subsequent improvement. Regardless, 
studying collateral functional vasodilation following arterial occlusion will elucidate the impact of 
arteriogenesis on the overall ability to increase blood flow. 
Sex appears to influence the vascular response to chronic ischemia, as functional claudication symptoms, 
potentially brought on by impaired vasodilation, are generally more severe in females [36,37]. Women 
experienced a sharper rise in PAOD-related death and disability over the past two decades [38,39], a trend 
that is expected to continue [40,41]. Although reports of overall sex differences in PAOD prevalence and 
outcomes are conflicting [42], women with the disease generally experience poorer physical function and 
a lower quality of life [43,44,45]. For example, women have a higher prevalence of critical limb ischemia, 
which is the most severe form of the disease [46,47]. Functional parameters that decline with intermittent 
claudication such as walking performance and ambulatory activity [48,49,50] are also more impaired in 
women than in men with symptomatic PAOD, accompanied by decreased microcirculatory function and 
increased circulating inflammatory markers [51]. There is also a sexually dimorphic response to chronic 
ischemia in animal models, as female mice have more impaired limb use and blood flow recovery [52]. In 
addition, females exhibited higher hindlimb vascular resistance in the ischemic hindlimb, which could 
result from either less revascularization or decreased vasodilation [52]. If females exhibit a greater 
impairment in function after occlusion, and these symptoms may be explained by impaired vasodilation, 
then there may be underlying sex differences in vasodilation following an ischemic event that are 
responsible for some of the sexually dimorphic response to PAOD.  
Exercise training is the most effective claudication therapy, equivalent to [53] or more functionally 
beneficial than [54] endovascular revascularization; therefore, it is recommended as a primary treatment 
for PAOD [55]. Because exercise improves claudication symptoms, the impact of intermittent 
claudication on vascular function may provide insight into the mechanisms of PAOD pathophysiology. 
Following occlusion, exercise training amplifies arteriogenic stimuli to increase collateral enlargement 
[56]. Additionally, regular exercise prior to arterial occlusion increases post-occlusive collateral-
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dependent hindlimb blood flow in rats [57], but it is unclear whether this is the result of enhanced 
arteriogenesis or improved vasodilation. Increased arteriogenesis is beneficial in that it allows greater 
blood flow to the ischemic zone. However, since different components of arteriogenesis may result in a 
transient impairment in vasodilation, which may be the cause of intermittent claudication, it is potentially 
more important for an effective treatment for PAOD to enhance functional hyperemia rather than 
augmenting post-occlusive structural adaptations. In non-ischemic animals, regular exercise increases 
functional vasodilation in skeletal muscle collateral arterioles, while only leading to a slight increase in 
vascular density [58], suggesting that the functional benefits of exercise may outweigh the structural 
adaptations. Furthermore, exercise training either pre- or post-occlusion improves endothelium-mediated 
collateral vasodilation [30,59], while simulation of exercise by chronic electrical stimulation enhances 
exercise performance [60]. These responses indicate that exercise training improves collateral function, 
given that collateral resistance is almost solely responsible for determining downstream blood flow during 
exercise [59,61]. However, functional vasodilation must be directly assessed in the collaterals to fully 
determine the therapeutic effects of exercise training. 
Although the treatment of PAOD and intermittent claudication with exercise is well documented, there is 
a lack of data concerning female patients, as only a small number of patients enrolled in exercise 
rehabilitation clinical trials have been women [62]. However, based on existing data, women with PAOD 
appear to be less responsive to therapeutic exercise training [63]. This diminished response to exercise 
could be attributed to the poorer baseline physical function observed in women with PAOD, including 
reduced daily ambulatory activity and hemoglobin oxygen saturation in the calf muscle [36,62]. Women 
also responded less efficaciously to exercise despite a similar ABI between sexes [37,64], suggesting that 
the difference between males and females is not an impairment in resting blood flow to the ischemic zone, 
but rather an impairment in the ability to increase blood flow as needed during exercise. Further 
comparison is necessary to determine sex differences in collateral vasodilation in response to ischemia 
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and exercise, as a reduction in both exercise performance and response to exercise therapy may be the 
result of impaired vascular reactivity. 
Impaired vasodilation is a potential explanation for intermittent claudication, and because the collateral 
circulation is the primary site of vascular resistance to the ischemic zone, impaired vasodilation in 
collaterals would have the greatest potential to induce claudication. Exercise training increases blood flow 
to the ischemic zone in male animal models, but it is unclear if this is a result of enhanced arteriogenesis 
or improved collateral vasodilation, while female patients respond more poorly to ischemia and may not 
experience the same therapeutic effects of exercise training. Because of these observations, we tested the 
hypotheses that functional vasodilation following femoral artery ligation is impaired in the immature 
gracilis collateral arteriole of mice and restored after maturation, that functional vasodilation is impaired 
more in females, and that exercise training improves functional vasodilation to a greater extent in males.  
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METHODS 
Animals 
All procedures were performed according to protocols approved by the California Polytechnic State 
University Institutional Animal Care and Use Committee. Male and female C57Bl/6 mice (Taconic 
Farms; Oxnard, CA) and male Balb/c mice (The Jackson Laboratory; Sacramento, CA) between 2 and 4 
months of age were used for all experiments. Mice were divided into sedentary and exercise-trained 
groups. C57Bl/6 mice were further divided into day 7 and day 28 groups (n=8 males, n=8 females each). 
For Balb/c mice, only the day 7 time-point was assessed for exercised and sedentary groups (n=6 males 
each). All mice were maintained on a 12-hour light/dark cycle and were given feed and water ad libitum. 
Mice were housed in microisolator cages and provided enrichment (nesting material, ‘house’, and plastic 
tube). In-cage running wheels (Columbus Instruments; Columbus, OH) were also provided for the 
exercise group immediately following surgery. 
Femoral Artery Ligation 
Chronic hindlimb ischemia was induced by ligating the femoral artery between the epigastric and 
popliteal branches, as described previously [65]. Animals were anesthetized in an induction chamber with 
5% isofluorane in oxygen flowing at 0.8-1.0 1·min-1. Following induction, isofluorane was decreased to 
2-3%. Hair was removed from the ventral aspect of both hindlimbs using depilatory cream, and skin was 
disinfected using chlorhexidine diacetate. Veterinary ophthalmic ointment was placed over the eyes to 
prevent corneal desiccation, and mice were given pre- and post-surgical buprenorphine analgesic (0.075 
mg·kg-1, subcutaneous). Body temperature was maintained at 35°C with a temperature-controlled heat 
pad and a rectal thermistor probe (CWE, Inc.; Ardmore, PA). The left femoral artery was separated from 
the adjacent nerve and vein and ligated with 6-0 silk suture, and the skin incision was closed with 7-0 
polypropylene suture. A sham surgery was performed in the right hindlimb, in which the connective 
tissue overlying the femoral neurovascular bundle was gently blunt dissected before skin closure. Mice 
were allowed to recover on a heat pad until ambulatory. 
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Ambulation Scoring 
Beginning after surgery, visual assessment of ambulation was conducted daily. Each mouse was given a 
score between 0 and 3 (3 = dragging hindpaw, 2 = dorsiflexion but no plantar flexion, 1 = some plantar 
flexion, and 0 = normal ambulation) until normal ambulation was observed for two consecutive days. 
Exercise Training 
Access to an exercise wheel (Columbus Instruments 8 Station Home Cage Running Wheel System) was 
provided post-surgery for mice in the exercise group. Wheel revolutions were detected using a magnetic 
indicator on the wheel and a Hall Effect sensor. Revolutions were counted using data acquisition software 
(Columbus Instruments Multi-Device Interface), and cumulative counts for each cage were recorded 
manually. The estimated distance run by each animal was calculated as the total distance run for the entire 
cage divided by the number of mice in the cage, and this number was divided by the number of days of 
observation to provide an estimate for the average distance run by each animal per day. 
Functional Vasodilation 
At day 7 or day 28 following surgery, animals were anesthetized as described above. Hair was removed 
from both the dorsal and ventral aspects of the hindlimbs using clippers and depilatory cream. The 
gracilis muscles were exposed via skin incision and resection of the epigastric fat pad; overlying fascia 
was removed by gentle blunt dissection. A custom trans-illuminating LED probe was placed under the 
hindlimb to allow visualization of the gracilis collateral arteriole, and two tungsten microelectrodes (FHC; 
Bowdoin, ME) were placed near the motor-end plates of the gracilis anterior, halfway between the 
profunda femoris artery and the saphenous artery. A stimulus isolator and data acquisition system 
(ADInstruments; Colorado Springs, CO, USA) were used to stimulate muscle contractions with 1 mA 
square waves of 0.2 ms duration at 1 Hz to confirm proper electrode placement. The preparation was 
irrigated with PBS, covered with plastic wrap, and given 30 minutes to equilibrate. After equilibration, 
the gracilis muscles were stimulated for 90 seconds with 1 mA square waves of 0.2 ms duration at 8 Hz. 
Images of the collateral midzone and the profunda femoris artery were captured before and immediately 
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after stimulation using an intravital microscope (Olympus BXFM) with a 10X objective (Olympus 
LMPlanFL N) and digital imaging software (QCapture Pro). The entire procedure was repeated for the 
contralateral hindlimb, after which mice were euthanized by cervical dislocation under general anesthesia. 
Measurements 
Vessel diameters were measured with ImageJ software. To examine any retest error introduced by this 
method of measurement, diameters were measured three separate times in the same day and then three 
times on a different day for a subset of images (n=6). The average standard deviation of the 
measurements for each image was 2.6 µm, while the average range was 7.3 µm. The intraclass correlation 
coefficient (ICC) was calculated to assess the reliability of these measurements, and was found to be 0.99, 
indicating a high retest correlation. Additionally, using a subset of the images that were not as clear 
(n=16), which tended to be those of the sham limb at rest, maximum and minimum possible diameters 
were measured. To determine potential measurement error resulting from variations in image quality, the 
average range between these values was calculated at 11.1 µm, causing the group average for this subset 
of images to have a lowest possible value of 24.3 µm or a highest possible value of 35.5 µm. 
Statistics 
Differences between resting and dilated diameters were assessed using paired t-tests. Percent changes in 
diameter were calculated as the difference between the dilated and resting diameters divided by the 
resting diameter and multiplied by 100%. Then, differences in resting diameter, dilated diameter, and 
percent change in diameter between males and females, operated and sham limbs, and day 7 and day 28 
time points were determined using either ANOVA and Tukey post-hoc comparisons for normal data or 
Kruskal-Wallis tests and Games-Howell comparisons for data that violated the ANOVA normality 
assumption (Table 1). Data are presented as mean ± SE. 
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Table 1. Comparisons made between experimental groups using Kruskal-Wallis tests. Each row contains two 
different experimental groups to be compared. Because at least one data set in each comparison listed violated the 
ANOVA normality assumption, non-parametric Kruskal-Wallis tests were used to compare median values. 
Experimental Group 1 
Group 1 
Normal? 
Experimental Group 2 
Group 2 
Normal? 
C57 Male Sedentary Operated Day 7 Yes C57 Male Sedentary Sham Day 7 No 
C57 Female Sedentary Sham Day 7 Yes C57 Male Sedentary Sham Day 7 No 
C57 Male Sedentary Sham Day 28 Yes C57 Male Sedentary Sham Day 7 No 
C57 Male Exercised Sham Day 7 Yes C57 Male Sedentary Sham Day 7 No 
C57 Female Exercised Operated Day 7 No C57 Female Exercised Sham Day 7 Yes 
C57 Female Exercised Operated Day 7 No C57 Male Exercised Operated Day 7 Yes 
C57 Female Exercised Operated Day 7 No C57 Female Sedentary Operated Day 7 Yes 
C57 Female Exercised Operated Day 28 Yes C57 Female Exercised Operated Day 7 No 
Balb/c Male Sedentary Sham Day 7 No C57 Male Sedentary Sham Day 7 No 
Balb/c Male Sedentary Operated Day 7 No Balb/c Male Sedentary Sham Day 7 No 
Balb/c Male Sedentary Operated Day 7 No C57 Male Sedentary Operated Day 7 Yes 
Balb/c Male Exercised Sham Day 7 Yes Balb/c Male Sedentary Sham Day 7 No 
Balb/c Male Exercised Operated Day 7 No Balb/c Male Exercised Sham Day 7 Yes 
Balb/c Male Exercised Operated Day 7  No Balb/c Male Sedentary Operated Day 7 No 
Balb/c Male Exercised Operated Day 7 No C57 Male Exercised Operated Day 7 Yes 
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RESULTS 
To test the hypothesis that arteriogenesis transiently impairs functional vasodilation, we used intravital 
microscopy to assess functional vasodilation in the collateral midzone 7 or 28 days following femoral 
artery ligation (Figure 1A, 1B). By day 7, the collateral arterioles had enlarged by arteriogenesis, as 
evidenced by dilated diameters in the operated limb (85 ± 4 µm in males; 83 ± 5 µm in females) that were 
greater than in the sham limb (62 ± 5 µm in males; 51 ± 3 µm in females) (Figure 1C). Operated limb 
resting diameters (75 ± 5 µm in males; 71 ± 6 µm in females) were also greater than in the sham limb (41 
± 4 µm in males; 32 ± 4 µm in females). Arteriogenesis was associated with a reduction in the dynamic 
range of the vessel, as the percent change in diameter in the operated limb was 16 ± 4 % for males and 18 
± 4 % for females, versus 55 ± 11 % for males and 64 ± 11 % for females in the sham limb (Figure 1D). 
Surprisingly, there were no differences in diameters between males and females at day 7. 
As expected, dilated diameter remained elevated in the operated limb at day 28 (88 ± 5 µm in males; 84 ± 
5 µm in females) in comparison to the sham (55 ± 4 µm in males; 58 ± 4 µm in females), reflecting the 
structural enlargement induced by arteriogenesis (Figure 1E). Interestingly, resting diameter in the 
operated limb was smaller at day 28 (55 ± 6 µm in males; 34 ± 3 µm in females) than at day 7, and was 
closer to sham values (33 ± 3 µm in males; 34 ± 3 µm in females). Because of this, functional 
vasodilation as measured by percent change in diameter (71 ± 17 % in males; 150 ± 16 % in females) was 
greater than at day 7 and no longer lower than in the sham limb (75 ± 14 % in males; 81 ± 22 % in 
females) (Figure 1F). Unexpectedly, operated limb resting diameter was smaller in females than in males, 
causing female percent change in diameter to be larger than the percent change in both males and the 
female sham. 
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Figure 1. Collateral functional vasodilation is impaired at day 7 and restored at day 28. Changes in vessel 
diameter were observed at the collateral midzone in sedentary mice at 7 days (A,C,D) or 28 days (B,E,F) post-
femoral artery ligation in the left hindlimb. White arrows indicate the collateral arteriole when multiple vessels are 
present in the field of view. At each time point, the gracilis muscles of male (n=8) and female (n=8) C57Bl/6 mice 
were stimulated with tungsten microelectrodes and an isolated stimulator. Visualization of the gracilis collateral 
arteriole was improved using trans-illumination, and images were acquired at rest and immediately after stimulation 
using intravital microscopy. At day 7, both the resting and dilated diameters were increased in the operated limb 
compared to the sham (C), and the percent change in vessel diameter was decreased (D). At day 28, the dilated 
diameter remained increased in comparison to the sham, but the resting diameters were smaller than at day 7 (E). 
Percent change in operated limb vessel diameter at day 28 was greater than at day 7, and either was comparable or 
increased compared to the sham (F). Functional vasodilation was similar between sexes at both time points, except 
for a smaller resting diameter and larger percent change in the female operated limb at day 28. (* p<0.05 vs. resting, 
# p<0.05 vs. sham, $ p<0.05 vs. day 7, % p<0.05 vs. male) 
To determine if exercise training, which alleviates claudication symptoms in patients and increases 
collateral-dependent blood flow in animal models, improves collateral vasodilation, mice were provided 
with in-cage running wheels immediately following femoral artery ligation. Interestingly, C57Bl/6 mice 
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in cages of two or three males  ran less per day on average (0.2 km and 0.8 km, respectively) than mice in 
cages with four males (2.6 km) or cages with females (2.9 km for two mice; 2.2 km for four mice) (Figure 
2). Male Balb/c mice housed with two animals per cage (1.3 km) ran more per day on average than 
C57Bl/6 mice in cages of two or three males, but they still ran less than male Balb/c mice housed with 
four animals per cage (1.9 km). 
 
Figure 2. Activity of exercise-trained mice. Animals in the exercise group were provided with in-cage running 
wheels post-femoral artery ligation. Total running distances were recorded for cages of two to four mice, and were 
divided by the number of mice in the cage to obtain an average value for running distance per mouse. C57Bl/6 mice 
in cages with two or three males ran less per day on average than mice in cages with four males or two or four 
females. Balb/c mice in cages of two also ran less per day on average than mice in cages of four. 
To test the hypothesis that reactivity is improved with voluntary exercise, functional vasodilation was 
assessed at the collateral midzone of exercise-trained mice at day 7 or day 28 (Figure 3A, 3B). Exercise 
training led to restoration of collateral dynamic range, as there were no differences in vessel diameter 
percent change between the operated and sham limbs at day 7 (44 ± 12 % versus 58 ± 7 % in males; 92 ± 
21 % versus 84 ± 15 % in females) (Figure 3D) or day 28 (101 ± 29 % versus 76 ± 13 % in males; 95 ± 
14 % versus 71 ± 13 % in females) (Figure 3F). This increase in functional vasodilation was accompanied 
by a general reduction in operated limb resting diameter, which was smaller than dilated diameter at both 
day 7 (62 ± 7 µm in males; 45 ± 6 µm in females) (Figure 3C) and day 28 (45 ± 7 µm in males; 44 ± 6 
µm in females) (Figure 3E). At day 7, female operated limb resting diameter was also smaller than in 
sedentary mice, and was no different from sham values (32 ± 3 µm in males; 30 ± 4 µm in females), while 
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at day 28, male operated limb resting diameter was no different from sham values (29 ± 2 µm in males; 
29 ± 2 µm in females). Similar to the observations in sedentary mice, the dilated diameter with voluntary 
exercise increased in the operated limb in comparison to the sham at day 7 (84 ± 6 µm versus 49 ± 4 µm 
in males; 77 ± 4 µm versus 53 ± 2 µm in females) and day 28 (79 ± 6 µm versus 50 ± 2 µm in males; 82 ± 
5 µm versus 48 ± 2 µm in females) due to arteriogenesis.  
 
Figure 3. Collateral functional vasodilation is improved with exercise training. Changes in vessel diameter were 
observed at the collateral midzone in exercise-trained mice at 7 days (A,C,D) or 28 days (B,E,F) post-femoral artery 
ligation in the left hindlimb. White arrows indicate the collateral arteriole when multiple vessels are present in the 
field of view. At each time point, the gracilis muscles of male (n=8) and female (n=8) C57Bl/6 mice were stimulated 
with tungsten microelectrodes and an isolated stimulator. Visualization of the gracilis collateral arteriole was 
improved using trans-illumination, and images were acquired at rest and immediately after stimulation using 
intravital microscopy. At day 7, the dilated diameters were increased in the operated limb compared to the sham, but 
female resting diameter was similar to the sham and decreased compared to sedentary mice, while resting diameter 
was smaller than dilated diameter for both sexes (C). The percent change in vessel diameter was similar in the 
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operated and sham limbs at day 7 (D). At day 28, the dilated diameters in the operated limb remained increased in 
comparison to the sham, but male resting diameter was similar to the sham, while resting diameter was smaller than 
dilated diameter for both sexes (E). Percent change in vessel diameter at day 28 was comparable in the both the 
operated and sham limbs (F). Functional vasodilation was similar between males and females at both time points. (* 
p<0.05 vs. resting, # p<0.05 vs. sham, $ p<0.05 vs. day 7, % p<0.05 vs. male, & p<0.05 vs. sedentary) 
In order to determine whether collateral diameter in the ischemic hindlimb is altered simply based on 
access to exercise, or if changes are dependent upon the amount of exercise performed, running distances 
and vessel diameters at rest and after stimulation were compared among the exercise-trained groups. 
There was a decreasing trend in resting diameter observed with increased running distance. However, 
dilated diameter did not appear to vary with running distance and remained fairly consistent in exercise-
trained animals. 
 
Figure 4. Relationship between access to exercise and collateral resting diameter. Male (n=8) and female (n=8) 
C57Bl/6 mice in the exercise group were provided with in-cage running wheels post-femoral artery ligation. Total 
running distances were recorded for cages of two to four mice, and were divided by the number of mice in the cage 
and then by the number of days of observation to obtain an average value for running distance per mouse per day. 
Gracilis collateral arteriole diameters at rest and after stimulation were observed at 7 days or 28 days post-ligation. 
A decreasing trend in collateral resting diameter was observed with increased running distance (A), while exercise 
did not appear to affect dilated diameters (B). 
Balb/c mice exhibit greater hypoxia than C57Bl/6 mice in both the collateral and calf regions of the 
hindlimb following occlusion [66]. To determine if a greater demand for oxygen and blood flow increases 
collateral resting diameter, decreasing the dynamic range of the vessel, functional vasodilation was 
measured at the midzone in sedentary Balb/c mice 7 days post-ligation (Figure 5A). As seen in C57Bl/6 
mice, both the resting and dilated diameters were increased in the operated limbs (65 ± 3 µm and 70 ± 3 
µm, respectively) in comparison to the sham limbs (33 ± 4 µm and 51 ± 4 µm, respectively) for the 
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sedentary group (Figure 5C). Additionally, the percent change in vessel diameter was smaller in the 
operated limb (9 ± 3 %) than in the sham limb (60 ± 11 %) (Figure 5D). Then, to evaluate the ability of 
therapeutic exercise to rescue vasodilation in a more hypoxic model, Balb/c mice were provided exercise 
wheels post-ligation and functional vasodilation was assessed at the midzone at day 7 (Figure 5B). 
Exercise training had a similar effect in Balb/c mice as it did in C57Bl/6 mice, as the operated limb 
dilated diameter (72 ± 6 µm) remained elevated compared to the sham (41 ± 2 µm), while the operated 
resting diameter appeared to decrease (53 ± 7 µm) but was still greater than the sham (26 ± 2 µm) (Figure 
5C). However, percent change in exercise-trained Balb/c mice was no different in the operated limb (49 ± 
25 %) and the sham limb (55 ± 6 %) (Figure 5D). 
 
Figure 5. Balb/c collateral functional vasodilation is impaired at day 7 but improved with exercise. Changes in 
vessel diameter were observed at the collateral midzone in sedentary (A) or exercise-trained (B) Balb/c mice at 7 
days post-femoral artery ligation in the left hindlimb. White arrows indicate the collateral arteriole when multiple 
vessels are present in the field of view. The gracilis muscles of male (n=6) Balb/c mice were stimulated with 
tungsten microelectrodes and an isolated stimulator. Visualization of the gracilis collateral arteriole was improved 
using trans-illumination, and images were acquired at rest and immediately after stimulation using intravital 
microscopy. In both sedentary and exercised mice, the resting and dilated diameters were increased in the operated 
limb compared to the sham, but resting diameter appeared closer to sham values with exercise (C). The percent 
change in vessel diameter was decreased in the operated limb of sedentary mice in comparison to the sham, but was 
greater than in sedentary mice and no different from the sham in exercise-trained mice (D). (* p<0.05 vs. resting, # 
p<0.05 vs. sham, @ p<0.05 vs. C57Bl/6)  
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To determine if exercise training could rescue a more hypoxic mouse model of ischemia, hindlimb 
functionality was assessed by exercise activity and ambulation in Balb/c mice. Running distances were 
similar for cages of Balb/c and C57Bl/6 mice with same number of mice per cage over the seven days 
following surgery (Figure 6B). However, by day 7 post-ligation, C57Bl/6 mice were more ambulatory 
than Balb/c mice (Figure 6A). Interestingly, no differences in ambulation were observed between 
sedentary and exercise-trained groups for either mouse strain. 
 
Figure 6. Activity and ambulation of exercise-trained Balb/c mice. Animals in the exercise group were provided 
with in-cage running wheels post-femoral artery ligation. Over the seven days post-ligation, total running distances 
were recorded for cages of two to four mice and ambulation was scored on a scale from 0 to 3 (3 = dragging 
hindpaw, 2 = dorsiflexion but no plantar flexion, 1 = some plantar flexion, and 0 = normal ambulation). Differences 
in ambulation patterns between strains were observed, as C57Bl/6 mice demonstrated close to normal ambulation by 
day 7 while Balb/c mice did not (A). Ambulation trends were similar between sedentary and exercise-trained groups 
for both mouse strains. Exercise activity was similar between Balb/c mice and C57Bl/6 mice in cages of four mice 
and cages of two or three mice (B).  
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DISCUSSION 
Patients with PAOD often present with intermittent claudication, which may be caused by impaired 
vasodilation. Impaired vasodilation in the collateral circulation is most likely to have the greatest impact, 
as it is the primary site of vascular resistance to the ischemic zone. Collateral vessel functionality 
following arterial occlusion is not well defined, although immature collaterals demonstrate impairments 
in both endothelial-dependent [22,23,24,25,26] and smooth muscle-dependent vasodilation [26,30,31]. 
There also appears to be a sexually dimorphic response to PAOD, as females generally exhibit poorer 
physical function. A common recommended therapy for intermittent claudication is exercise training, but 
it is unclear if exercise improves blood flow and alleviates claudication primarily by enhancing structural 
adaptations or vascular reactivity. Furthermore, females with PAOD may not respond to therapeutic 
exercise training as efficaciously as males, warranting a comparison of the impact of exercise on 
collateral vasodilation between the sexes. Therefore, we assessed functional vasodilation in immature and 
mature collaterals, in females and males, and with or without exercise training  
As expected,  functional vasodilation was ‘impaired’ at day 7, ‘restored’ by day 28, and ‘improved’ with 
exercise, as measured by percent change in collateral diameter, a common presentation of vascular 
reactivity [67,68,69]. However, a closer examination of the data reveals that this percent change was 
largely influenced by decreases in resting vessel diameter, and not the expected increase in dilated vessel 
diameter. Surprisingly, collateral diameter following muscle contraction (i.e. functional vasodilation) was 
similar between males and females at both time points in sedentary and exercised mice. 
Immature collateral arterioles exhibited large resting diameters and consequently, minimal reactivity at 
day 7. This could be due to a number of factors. First, the sustained diameter increase observed could be 
due to a loss of sympathetic tone, resulting in decreased vasoconstriction via decreased activation of α-
adrenergic receptors. In canine models, α-adrenergic stimulation failed to produce a vasoconstriction 
response in coronary collateral vessels at both immature and mature stages of development, indicating 
that these collaterals do not contain functioning α-adrenergic receptors [70, 71]. The studies in mature 
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collaterals were performed six months after arterial occlusion, which is roughly the time period required 
for development of the collateral vessel wall in canine models [72]. Additionally, there is a lack of data 
regarding collateral response to adrenergic agents in small animal models. Therefore, although increased 
resting diameters were only observed in immature collaterals in our study, this decrease in α-adrenergic 
modulation may still be relevant, as collateral maturation occurs more quickly in mice [65,73] and may be 
varied between coronary and hindlimb collateral circuits [74].To determine this relevance, collateral 
sympathetic tone and adrenergic responsiveness could be assessed in the murine hindlimb by applying an 
α-blocker and an α-agonist, respectively. If elevated resting diameters are caused by reduced sympathetic 
tone or adrenergic responsiveness, then a blunted response to either or both agents would be expected. 
If a loss of adrenergic tone is responsible for the large resting diameters of immature collaterals, the 
decrease in resting diameter seen in exercise-trained mice at day 7 indicates some restoration of 
sympathetic influence. In exercise-trained animals, non-specific inhibition of α-adrenergic receptors 
increased collateral conductance post-acute femoral artery occlusion [61], suggesting that sympathetic 
tone may be increased with exercise training. However, conductance was measured during treadmill 
running [61], and throughout periods of exercise, sympathetic tone is increased to elevate heart rate and 
constrict non-active vascular beds to enhance blood flow to active skeletal muscle, tempering the rapid 
elevation in blood flow that occurs at the onset of exercise [75]. Based on this, it is unclear if the 
improvement in sympathetic tone due to training is lasting or merely transient, presenting only during 
exercise. Other studies provide evidence for a more permanent sympathetic tone increase- adrenergic 
vasoconstriction is enhanced in the skeletal muscle arterioles of trained rats at rest [76]. The ability of 
exercise to restore adrenergic tone could explain the decrease in the immature collateral resting diameter 
of exercise-trained mice in comparison to sedentary mice. 
Another explanation for the observed increase in immature collateral resting diameter at day 7 is that the 
hypoxic downstream environment created after ligation increases the demand for oxygen and blood flow, 
essentially promoting a prolonged state of vasodilation. Long periods of exposure to vasoconstrictor 
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agents inhibit the ability of resistance arterioles to return to the initial diameter after the vasoconstrictor 
stimulus is removed, as the vessels begin to remodel inwardly [77,78]. The opposite phenomenon can 
also occur due to elevated downstream flow demand, and long-term vasodilation of the collateral vessels 
may lead to outward remodeling. For instance, mechanoadaptation leads to reorientation, but not 
proliferation, of smooth muscle cells in the profunda femoris feed artery to increase vessel diameter 
following arterial occlusion [79]. In contrast to the slight hypoxia in C57Bl/6 mice present only 
immediately after ligation, Balb/c mice exhibit severe hypoxia in the thigh region immediately and in the 
calf after 7 days [66]. A greater increase in resting diameter and decrease in reactivity in Balb/c mice, a 
more hypoxic model, would indicate that the state of the ischemic zone is a large determinant of resting 
diameter. However, the vessel diameters and functional vasodilation were similar at day 7 in C57Bl/6 
mice and Balb/c mice. That being said, because the resting and dilated diameters were so close and the 
change in diameter was almost negligible in C57Bl/6 mice at day 7, it would be difficult to observe a 
more significant resting diameter increase or vasodilatory impairment, so this interpretation remains 
somewhat inconclusive.  
A third cause for the increase in resting diameter at day 7 could be the lack of a contractile phenotype in 
vascular smooth muscle cells. During arteriogenesis, smooth muscle cells differentiate from a contractile 
to a synthetic phenotype for proliferation and migration [80]. This synthetic state is non-contractile yet 
reversible; the smooth muscle cells regain contractility as vessel development progresses [80,81]. Smooth 
muscle cell differentiation back to a contractile phenotype could also explain the observation that, in 
contrast to the increased resting diameters of immature collaterals at day 7, the diameters of mature 
collaterals at day 28 were smaller at rest. At day 28, resting diameters in the operated limb resembled 
those in the sham limbs more closely than they did those in the operated limbs at day 7, indicating an 
improved vascular tone. This is similar to the response observed in feed arteries previously by our group; 
the resting diameter of the profunda femoris artery was elevated at day 7 but returned to sham values by 
day 28 after the completion of feed artery outward remodeling [29]. In the profunda, there is no smooth 
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muscle cell proliferation [35], so this response is likely due to smooth muscle cell mechanoadaptation 
[29]. However, because smooth muscle cell proliferation does occur during arteriogenesis in the 
collaterals, the transition from a synthetic phenotype back to a contractile one may be responsible for the 
decrease in resting diameter we observed in the current study between day 7 and day 28. Furthermore, 
exercise training maintains a contractile smooth muscle phenotype in coronary vascular smooth muscle 
[82], which could explain why exercise training decreased collateral resting diameters and increased 
reactivity. Alterations in vascular smooth muscle contractile state are able to describe the diameter and 
reactivity trends observed throughout collateral maturation, including the increased resting diameter at 
day 7 and the decrease in resting diameter with exercise and in mature collaterals at day 28. 
An alternative interpretation of the decrease in resting diameter over time is that the gracilis collateral is 
not the primary collateral at day 28 following ligation. Although the gracilis collateral is the primary 
collateral at day 14 following ligation in this model [83], not all collateral vessels are of equal importance 
in the hindlimb circulation, and the relative contribution of each collateral can vary over time [3]. With a 
decrease in flow and shear stress, decompensation and inward remodeling can occur [84]; many vessels 
begin to increase diameter upon occlusion, but only a few remain enlarged after chronic vascular 
adaptation is complete [85]. For instance, in rats, the perforating artery is enlarged at 7 days [86] but not 
at 14 days post-femoral artery ligation in comparison to the non-ligated control [73], while the superficial 
circumflex iliac artery remains enlarged after 14 days [3]. This suggests that while both vessels are 
important as collaterals initially, the superficial circumflex iliac artery is the primary collateral while the 
perforating artery is not. Because the gracilis arteriole in the mouse followed the same diameter pattern as 
the rat perforating artery, it may not be as important later in the collateral development process. 
Furthermore, a similar remodeling trend was observed previously in this specific vessel, although in 
response to a different alteration in blood supply; the average diameter of the gracilis arteriole increased, 
peaked at 21 days, and then decreased following removal of one of its feed arteries [87,88]. Although 
these studies were performed using maximally dilated preparations while our results showed decreased 
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resting diameter but no variation in maximum diameter, they still support the idea that collateral 
enlargement is not permanent or static. Determining if the gracilis collateral remains the primary hindlimb 
collateral at day 28 could be accomplished by perfusing with a silicone injection casting compound and 
observing the quickest collateral path to the saphenous artery [83]. The importance of the gracilis 
collateral could further be evaluated by occluding the gracilis collateral at day 28 and measuring the 
resting blood flow and hyperemia in the distal leg. 
The decrease in collateral reactivity observed at day 7 was not surprising, based on previous reports of 
impaired endothelium-dependent and smooth muscle-dependent vasodilation in maturing collaterals 
[22,23,24,25,26,30,31]. While decreased endothelial functionality could be the cause of the observed lack 
of vascular reactivity, smooth muscle dysfunction is a more likely cause, given the attenuation of 
endothelium-dependent and endothelium-independent reactivity, which both are contingent upon smooth 
muscle cell function. At day 28, reactivity in the collaterals matched, and even surpassed, that of control 
collaterals. This was expected, based on previous work by our group, demonstrating that endothelium-
dependent, smooth muscle-dependent, and functional vasodilation were all impaired in immature feed 
arteries but restored after maturation [29]. In the present study, collateral functional vasodilation followed 
the same pattern, potentially due to alterations of smooth muscle cell phenotype during arteriogenesis, as 
discussed earlier. Additionally, exercise training improved functional vasodilation in both immature and 
mature collaterals. This was also expected, based on the knowledge that exercise training augments 
endothelial-dependent dilation of collateral vessels and exercise performance [30,89] and also maintains a 
contractile smooth muscle phenotype in coronary vascular smooth muscle [82]. 
Compared to sedentary mice at day 7 post-ligation, exercise training increased vascular reactivity as 
measured by percent change in vessel diameter at both day 7 and day 28, and also decreased resting 
diameter. These effects are similar to those observed in sedentary mice at day 28; it appears that resting 
diameter decreases throughout gracilis collateral maturation, and exercise training expedites the process. 
Generally, mice with greater exercise activity had smaller resting diameters, although this trend is based 
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on estimating the distance run by each individual mouse in multi-mouse cages. However, the data indicate 
that access to a running wheel reduces resting diameter and, consequently, improves collateral 
vasodilation, as hypothesized. The observation that exercise enhances vascular reactivity also warranted 
investigation into the extent of its therapeutic potential. To see if exercise training could rescue a more 
hypoxic mouse model of hindlimb ischemia, functional vasodilation was assessed in Balb/c mice. Similar 
to the C57Bl/6 mice, there was a decreasing trend in resting diameter and an increasing trend in percent 
change in diameter at day 7 post-ligation for exercise-trained Balb/c mice in comparison to sedentary 
Balb/c mice. Based on these results, exercise enhances vasodilation despite a more severe hypoxic 
environment downstream and transient severe hypoxia in the region of collateral growth [66]. Although 
exercise activity was similar in Balb/c and C57Bl/6 mice, ambulation was still noticeably more impaired 
in Balb/c mice over the seven days post-ligation, indicating that the more hypoxic environment in Balb/c 
mice has a physical impact despite improvements in vasodilation. To further address the question of 
whether or not improved collateral vasodilation helps physical functionality, downstream force 
production could be measured in the ischemic hindlimbs of exercise-trained mice. 
Although arteriogenic processes involving endothelial or smooth muscle cells are potentially responsible 
for reduced collateral vasodilation in general, percent change in vessel diameter was largely dependent on 
collateral resting diameter and not the diameter after stimulation. The fact that our dilated diameters were 
consistent among the different groups while resting diameters were not suggests that the vessels 
remodeled as much as was necessary to normalize maximal shear stress, which may be similar during 
exercise and daily locomotion, and not in response to average shear stress, which is likely increased with 
exercise. Additionally, maximum collateral diameter may be a more accurate reflection of arteriogenesis 
than resting diameter. In large animal models, administration of vasodilator agents significantly increases 
flow and decreases resistance in coronary vessels during maximal exercise, indicating a substantial 
coronary vasodilator reserve [90]. A similar preserved vasodilator capacity is also seen in collaterals, 
since during exercise, resistance vessels in the coronary collateral region vasodilate to increase blood flow 
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without a decrease in transcollateral resistance [90]. Taken together, these observations suggest that in 
collaterals and even at maximal exercise intensity, a vasodilator reserve is present; it stands to reason that 
the same could be true in the hindlimb collateral circulation, meaning that electrode stimulation may not 
produce a true maximal vessel diameter. Furthermore, vascular remodeling is most commonly classified 
according to a scheme that bases its occurrence on the passive, or fully relaxed, luminal diameter [78]. 
Therefore, in the future, maximally dilating with sodium nitroprusside and adenosine at the end of each 
experiment may provide a better indication of any diameter change caused by arteriogenesis. As for 
resting diameter, there is a lack of reported values for this parameter, as it is a common practice to assess 
reactivity in collateral vessels by measuring vascular resistance and conductance [30,52,57,59,61] or to 
dilate the vessels before measuring diameter [34,65,72,78]. The physiological significance of collateral 
diameter at rest remains unclear, but our results may provide insight as to the elements influencing its 
variation. 
However, it is also necessary to note that the observed decrease in collateral resting diameter and 
improvement in vasodilation with exercise could be due to other physiological adaptations not directly 
related to the vasculature. For instance, mitochondrial biogenesis is induced in skeletal muscle as a result 
of exercise training [91], along with increases in citrate synthase activity and protein content and activity 
of electron transport chain components [92]. Another adaptation that occurs with exercise is skeletal 
muscle fast-twitch fiber type switching from type IIb to type IIx and type IIa, which is an oxidative fiber 
type [91, 93]. Furthermore, exercise training increases myoglobin concentration in fast-twitch oxidative 
muscles [94], which may improve oxygen storage and delivery to the mitochondria. Increased number of 
mitochondria, improved mitochondrial efficiency, and increased myoglobin likely promote better oxygen 
utilization, which might decrease the demand for blood flow. Alterations in metabolite transport might 
have a similar effect, as both glucose and fatty acid transport proteins are increased with exercise training 
[95,96]. Any combination of these non-vascular adaptations may contribute to the decrease in collateral 
resting diameter perceived with exercise. 
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As mentioned earlier, a limitation of this study was that the activity of the exercise-trained mice was 
obtained by cage instead of by individual mouse. Because of this, we were only able to estimate the 
distance run by each animal as the total distance run for the entire cage divided by the number of mice in 
the cage. Interestingly, estimated activity per animal in cages with two or three males was less than those 
in cages with four males or in cages with females. This is possibly because of aggression brought on by 
the addition of an exercise wheel to the cage; possessive behavior was observed in cages with two or three 
males that also had low exercise activity, but was not seen among females or in cages with four males. 
Furthermore, access to exercise appeared to decrease collateral resting diameter at day 7 in females, but 
exercised males were not different from sedentary animals at this time point. Because the cages with 
aggression and low exercise contained males in this group, these animals likely did not fully experience 
the vascular adaptations demonstrated in the other exercise-trained groups. If individual exercise wheel 
activity had been monitored, it would have been possible to determine how much each animal was 
running in situations like this, and for all of the other cages. In the future, this could be accomplished by 
tracking each mouse with a unique radio-frequency identification tag that would register which mouse 
was on the exercise wheel. However, this first study exploring exercise indicates that access to exercise 
decreases collateral resting diameter and increases vasodilation. 
Even without exercise as a factor, aggression-induced stress may still have influenced collateral 
maturation during the recovery from chronic ischemia. In sedentary mice at day 28, females had a large 
increase in reactivity in comparison to day 7, while males did not. Some of the males in this group 
exhibited aggression post-surgery, requiring separation and isolation housing for multiple weeks of 
recovery. Mice respond poorly to isolation housing as assessed by both behavioral and physiological 
changes [97]. In addition to altered food intake, organ weights, anxiety-like reactions, and body 
temperature in isolated mice [98,99,100,101], differences in cardiovascular parameters were also 
observed, including increased heart rate [101]. Therefore, it is possible that the stress of isolation 
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diminished the restoration of collateral dynamic range, leading to this inconsistency between males and 
females. 
Aside from the discrepancies between sexes mentioned above that may have been the result of 
aggression-induced stress and lack of activity, there were no major differences observed between males 
and females. While clinical data suggests that female patients with PAOD experience more impairment 
physically and respond less efficaciously to therapeutic exercise, female mice in this study recovered their 
vasodilatory capabilities both with collateral maturation and with access to exercise just as well as males 
did, and in some cases even more effectively. It is not surprising that these observations are varied in 
human patients when compared to our animal model, as the female mice used in this study were young 
and healthy. The sexually dimorphic response seen clinically may emerge with additional co-morbidities 
or risk factors for PAOD present, or as a result of estrogen deficiency. For instance, hypercholesterolemia 
and ovariectomy in female mice each lead to impaired endothelial-dependent vasodilation in the 
resistance vessels [102]. This finding is accompanied by controversial reports regarding the influence of 
sex on atherosclerosis [103]; recent studies show that atherosclerotic lesions in apolipoprotein E-deficient 
mice are more prevalent in females [104,105,106]. Whether impaired female vascular function is a result 
of worse disease progression or poorer adaptation, diseased animal models have greater potential to more 
accurately represent the sexually dimorphic response observed in human patients with PAOD. 
Finally, although the retest correlation of vessel diameter measurements made using our methods was 
high and the standard deviation and range of these measurements were relatively small, certain methods 
could be implemented in future experiments to further minimize this error resulting from measurement 
variation. Blinded measurements would help to eliminate bias based on the identity of each experimental 
group, while obtaining and averaging multiple measurements for each diameter value would improve 
accuracy. Additionally, measurement accuracy could be improved by minimizing the error present due to 
poorer-quality images. Image processing techniques such as threshold image analysis might improve the 
contrast between the blood vessels and the surrounding tissue in each image, more clearly defining the 
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vessel walls and allowing for more accurate diameter measurements. To improve collateral visualization 
further before image capture, a contrast agent such as Evans blue could be injected into the bloodstream 
and viewed with white light. Alternatively, a fluorescent contrast agent such as fluorescein 
isothiocyanate-dextran (FITC-dextran) might achieve better visualization for improved image quality. If a 
blue light of the proper wavelength was used with the current trans-illumination method, it could excite 
the FITC-dextran in the collateral circulation, which might allow for better images acquired with a 
fluorescent microscope. Utilizing these methods in the future would likely improve the accuracy of blood 
vessel diameter measurements. 
Functional vasodilation as assessed by vascular dynamic range is impaired in immature collateral vessels 
and restored with maturation. This reinforces the hypothesis that intermittent claudication may be the 
result of impaired vasodilation. Because the collateral circulation is the primary site of resistance to the 
ischemic zone, impaired collateral vasodilation would likely have the greatest impact. Additionally, 
exercise training appears to enhance collateral reactivity, suggesting that its therapeutic benefits are linked 
not only to structural adaptation but also to vessel functionality. However, we found that vascular 
reactivity is largely dependent on resting diameter, while diameter after stimulation remained consistent 
among groups. Therefore, further research is required to determine the functional relevance of collateral 
resting diameter in the ischemic limb circulation. 
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APPENDICES 
Appendix A: Surgery and Experimental Protocols 
Femoral Artery Ligation Protocol 
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Functional Vasodilation Protocol 
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Sample Images of Experimental Set-Up 
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Appendix B: Sample Raw Images 
C57Bl/6 Male Sedentary Day 7 Operated 
 
C57Bl/6 Male Sedentary Day 7 Sham 
 
C57Bl/6 Male Sedentary Day 28 Operated 
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C57Bl/6 Male Sedentary Day 28 Sham 
 
C57Bl/6 Male Exercise-Trained Day 7 Operated 
 
C57Bl/6 Male Exercise-Trained Day 7 Sham 
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C57Bl/6 Male Exercise-Trained Day 28 Operated 
 
C57Bl/6 Male Exercise-Trained Day 28 Sham 
 
C57Bl/6 Female Sedentary Day 7 Operated 
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C57Bl/6 Female Sedentary Day 7 Sham 
 
C57Bl/6 Female Sedentary Day 28 Operated 
 
C57Bl/6 Female Sedentary Day 28 Sham 
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C57Bl/6 Female Exercise-Trained Day 7 Operated 
 
C57Bl/6 Female Exercise-Trained Day 7 Sham 
 
C57Bl/6 Female Exercise-Trained Day 28 Operated 
  
43 
 
C57Bl/6 Female Exercise-Trained Day 28 Sham 
 
Balb/c Male Sedentary Day 7 Operated 
 
Balb/c Male Sedentary Day 7 Sham 
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Balb/c Male Exercise-Trained Day 7 Operated 
 
Balb/c Male Exercise-Trained Day 7 Sham 
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Appendix C: Raw Data 
C57Bl/6 Functional Vasodilation Data 
Sex Treatment Limb 
Time 
Point 
Replicate 
Cage 
# 
Resting 
(µm) 
Dilated 
(µm) 
Percent 
change (%) 
M Sedentary Operated Day 7 1 4 77.6 81.9 5.541237 
M Sedentary Operated Day 7 2 4 83.2 84.8 1.923077 
M Sedentary Operated Day 7 3 6 85.3 96 12.54396 
M Sedentary Operated Day 7 4 6 60.6 75.4 24.42244 
M Sedentary Operated Day 7 5 3 54.2 68.8 26.93727 
M Sedentary Operated Day 7 6 3 75.3 83.3 10.62417 
M Sedentary Operated Day 7 7 18 60.6 84.2 38.94389 
M Sedentary Operated Day 7 8 5 103.4 108.5 4.932302 
M Sedentary Operated Day 7 9  71.1 81.6 14.76793 
M Sedentary Operated Day 28 1 4 85.1 104.1 22.32667 
M Sedentary Operated Day 28 2 4 63.1 75 18.85895 
M Sedentary Operated Day 28 3 6 52.7 72.1 36.81214 
M Sedentary Operated Day 28 4 6 64.9 107.2 65.1772 
M Sedentary Operated Day 28 5 3 35.4 81.6 130.5085 
M Sedentary Operated Day 28 6 3 34.7 82.5 137.7522 
M Sedentary Operated Day 28 7 18 50 92.5 85 
M Sedentary Operated Day 28 8 5 52.8 91.8 73.86364 
M Sedentary Sham Day 7 1 3a → 3b 
   
M Sedentary Sham Day 7 2 3a 35.3 53 50.14164 
M Sedentary Sham Day 7 3 3 35.5 52.6 48.16901 
M Sedentary Sham Day 7 4 3 42.4 59.6 40.56604 
M Sedentary Sham Day 7 5 1 57.1 80.9 41.68126 
M Sedentary Sham Day 7 6 1 41 57.9 41.21951 
M Sedentary Sham Day 7 7 1 
   
M Sedentary Sham Day 7 8 1 33.5 69.7 108.0597 
M Sedentary Sham Day 28 1 3a → 3b 39 62 58.97436 
M Sedentary Sham Day 28 2 3a 26.7 38.8 45.31835 
M Sedentary Sham Day 28 3 3 
   
M Sedentary Sham Day 28 4 3 25.6 51.7 101.9531 
M Sedentary Sham Day 28 5 1 32.9 52.6 59.87842 
M Sedentary Sham Day 28 6 1 22.2 55.4 149.5495 
M Sedentary Sham Day 28 7 1 39.7 56.6 42.56927 
M Sedentary Sham Day 28 8 1 41.9 70 67.06444 
M Exercised Operated Day 7 1 1 90.8 114.2 25.77093 
M Exercised Operated Day 7 2 1 32 52.7 64.6875 
M Exercised Operated Day 7 3 15 39.2 81.4 107.6531 
M Exercised Operated Day 7 4 15 70.8 84.1 18.78531 
M Exercised Operated Day 7 5 1 76.4 80.6 5.497382 
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M Exercised Operated Day 7 6 1 49.8 70.4 41.36546 
M Exercised Operated Day 7 7 2 54.1 91.5 69.13124 
M Exercised Operated Day 7 8 2 78.5 93.7 19.36306 
M Exercised Operated Day 28 1 1 46.3 105.7 128.2937 
M Exercised Operated Day 28 2 1 48.4 69.7 44.00826 
M Exercised Operated Day 28 3 15 26.2 87.3 233.2061 
M Exercised Operated Day 28 4 15 34.9 87.7 151.2894 
M Exercised Operated Day 28 5 1 28.5 75.6 165.2632 
M Exercised Operated Day 28 6 1 88 88.6 0.681818 
M Exercised Operated Day 28 7 2 47.1 49.5 5.095541 
M Exercised Operated Day 28 8 2 37.7 69.1 83.28912 
M Exercised Sham Day 7 1 1 19.2 30.1 56.77083 
M Exercised Sham Day 7 2 1 23.5 46.2 96.59574 
M Exercised Sham Day 7 3 2 31.2 42.9 37.5 
M Exercised Sham Day 7 4 2 31.7 56.8 79.17981 
M Exercised Sham Day 7 5 6 33.3 47.1 41.44144 
M Exercised Sham Day 7 6 6 47.1 65.4 38.8535 
M Exercised Sham Day 7 7 25 29 43.8 51.03448 
M Exercised Sham Day 7 8 25 37.6 61.6 63.82979 
M Exercised Sham Day 28 1 1 23.8 57.3 140.7563 
M Exercised Sham Day 28 2 1 35.1 57.9 64.95726 
M Exercised Sham Day 28 3 2 23.8 44.5 86.97479 
M Exercised Sham Day 28 4 2 29.7 50.3 69.36027 
M Exercised Sham Day 28 5 6 
   
M Exercised Sham Day 28 6 6 31.7 43.4 36.90852 
M Exercised Sham Day 28 7 25 32.9 46.6 41.64134 
M Exercised Sham Day 28 8 25 25.5 49.2 92.94118 
F Sedentary Operated Day 7 1 5a 61.2 72.6 18.62745 
F Sedentary Operated Day 7 2 5a 77 90 16.88312 
F Sedentary Operated Day 7 3 4a 48.5 59.5 22.68041 
F Sedentary Operated Day 7 4 4a 97.1 104 7.106076 
F Sedentary Operated Day 7 5 4a 53 76.4 44.15094 
F Sedentary Operated Day 7 6 21 90.6 100 10.37528 
F Sedentary Operated Day 7 7 21 66.4 78.5 18.22289 
F Sedentary Operated Day 7 8 21 75.9 80.3 5.797101 
F Sedentary Operated Day 28 1 5a 31.3 91 190.7348 
F Sedentary Operated Day 28 2 5a 26 79.2 204.6154 
F Sedentary Operated Day 28 3 4a 28.2 76.5 171.2766 
F Sedentary Operated Day 28 4 4a 33.5 79 135.8209 
F Sedentary Operated Day 28 5 4a 37 74.1 100.2703 
F Sedentary Operated Day 28 6 21 35.6 65 82.58427 
F Sedentary Operated Day 28 7 21 50 108.5 117 
F Sedentary Operated Day 28 8 21 33.1 97.7 195.1662 
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F Sedentary Sham Day 7 1 24 25 54.7 118.8 
F Sedentary Sham Day 7 2 24 27.7 50 80.50542 
F Sedentary Sham Day 7 3 24 32.9 49.3 49.84802 
F Sedentary Sham Day 7 4 24 46.5 66.1 42.15054 
F Sedentary Sham Day 7 5 9 
 
50.3 
 
F Sedentary Sham Day 7 6 9 23.7 36.4 53.5865 
F Sedentary Sham Day 7 7 9 26.6 45.8 72.18045 
F Sedentary Sham Day 7 8 9 44.2 58.9 33.25792 
F Sedentary Sham Day 28 1 24 33 47.2 43.0303 
F Sedentary Sham Day 28 2 24 30.8 53.2 72.72727 
F Sedentary Sham Day 28 3 24 
   
F Sedentary Sham Day 28 4 24 47.6 56.2 18.06723 
F Sedentary Sham Day 28 5 9 35.2 56.9 61.64773 
F Sedentary Sham Day 28 6 9 26.3 60.6 130.4183 
F Sedentary Sham Day 28 7 9 35.8 54.2 51.39665 
F Sedentary Sham Day 28 8 9 26.4 76.7 190.5303 
F Exercised Operated Day 7 1 6a 45.5 63.5 39.56044 
F Exercised Operated Day 7 2 6a 26.7 65.8 146.4419 
F Exercised Operated Day 7 3 22 51.5 69.5 34.95146 
F Exercised Operated Day 7 4 22 63.6 87.6 37.73585 
F Exercised Operated Day 7 5 8 76.4 80.4 5.235602 
F Exercised Operated Day 7 6 8 37.9 94.9 150.3958 
F Exercised Operated Day 7 7 8 29.6 78.5 165.2027 
F Exercised Operated Day 7 8 8 29.3 75.1 156.314 
F Exercised Operated Day 28 1 6a 28.5 59.7 109.4737 
F Exercised Operated Day 28 2 6a 80.3 91.4 13.82316 
F Exercised Operated Day 28 3 22 45.1 94.9 110.4213 
F Exercised Operated Day 28 4 22 43.1 68.6 59.16473 
F Exercised Operated Day 28 5 8 35.2 67.3 91.19318 
F Exercised Operated Day 28 6 8 42.1 95.6 127.0784 
F Exercised Operated Day 28 7 8 41.8 91.9 119.8565 
F Exercised Operated Day 28 8 8 38 88.3 132.3684 
F Exercised Sham Day 7 1 7 22.3 54.1 142.6009 
F Exercised Sham Day 7 2 7 22.7 46.2 103.5242 
F Exercised Sham Day 7 3 7 35.8 55.2 54.18994 
F Exercised Sham Day 7 4 7 31 54.1 74.51613 
F Exercised Sham Day 7 5 2 27.8 54.5 96.04317 
F Exercised Sham Day 7 6 2 33.7 49.8 47.77448 
F Exercised Sham Day 7 7 2 42.1 62.1 47.50594 
F Exercised Sham Day 7 8 2 23.6 48.9 107.2034 
F Exercised Sham Day 28 1 7 33.9 49.4 45.72271 
F Exercised Sham Day 28 2 7 26.3 57.5 118.6312 
F Exercised Sham Day 28 3 7 23.7 40.5 70.88608 
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F Exercised Sham Day 28 4 7 35.4 45.3 27.9661 
F Exercised Sham Day 28 5 2 
   
F Exercised Sham Day 28 6 2 25.7 47.9 86.38132 
F Exercised Sham Day 28 7 2 27.7 49 76.89531 
F Exercised Sham Day 28 8 2 
   
 
C57Bl/6 Exercise Data 
Sex Treatment Limb 
Time 
Point 
Replicate 
Cage 
# 
Mice 
per 
cage 
Total 
revolutions 
Total 
distance 
(km) 
Avg 
distance 
per day 
(km) 
M Exercised Operated Day 7 1 1 2 1190.5 0.344086 0.049155 
M Exercised Operated Day 7 2 1 2 6283.5 1.816098 0.259443 
M Exercised Operated Day 7 3 15 3 18572 5.367801 0.766829 
M Exercised Operated Day 7 4 15 3 24599 7.109763 1.01568 
M Exercised Operated Day 7 5 1 3 24599 7.109763 1.01568 
M Exercised Operated Day 7 6 1 3 14369 4.152829 0.593261 
M Exercised Operated Day 7 7 2 3 18181 5.254599 0.750657 
M Exercised Operated Day 7 8 2 3 18181 5.254599 0.750657 
M Exercised Operated Day 28 1 1 2 1190.5 0.344086 0.049155 
M Exercised Operated Day 28 2 1 2 6283.5 1.816098 0.259443 
M Exercised Operated Day 28 3 15 3 18572 5.367801 0.766829 
M Exercised Operated Day 28 4 15 3 24599 7.109763 1.01568 
M Exercised Operated Day 28 5 1 3 24599 7.109763 1.01568 
M Exercised Operated Day 28 6 1 3 14369 4.152829 0.593261 
M Exercised Operated Day 28 7 2 3 18181 5.254599 0.750657 
M Exercised Operated Day 28 8 2 3 18181 5.254599 0.750657 
M Exercised Sham Day 7 1 1 4 299376 86.5276 3.090272 
M Exercised Sham Day 7 2 1 4 299376 86.5276 3.090272 
M Exercised Sham Day 7 3 2 4 311248.5 89.95907 3.212824 
M Exercised Sham Day 7 4 2 4 311248.5 89.95907 3.212824 
M Exercised Sham Day 7 5 6 4 207080 59.85161 3.150085 
M Exercised Sham Day 7 6 6 4 207080 59.85161 3.150085 
M Exercised Sham Day 7 7 25 4 207080 59.85161 3.150085 
M Exercised Sham Day 7 8 25 4 207080 59.85161 3.150085 
M Exercised Sham Day 28 1 1 4 299376 86.5276 3.090272 
M Exercised Sham Day 28 2 1 4 299376 86.5276 3.090272 
M Exercised Sham Day 28 3 2 4 311248.5 89.95907 3.212824 
M Exercised Sham Day 28 4 2 4 311248.5 89.95907 3.212824 
M Exercised Sham Day 28 5 6 4 207080 59.85161 3.150085 
M Exercised Sham Day 28 6 6 4 207080 59.85161 3.150085 
M Exercised Sham Day 28 7 25 4 207080 59.85161 3.150085 
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M Exercised Sham Day 28 8 25 4 207080 59.85161 3.150085 
F Exercised Operated Day 7 1 6a 2 93005 26.88091 3.84013 
F Exercised Operated Day 7 2 6a 2 93005 26.88091 3.84013 
F Exercised Operated Day 7 3 22 2 93804 13.55592 1.93656 
F Exercised Operated Day 7 4 22 2 93804 13.55592 1.93656 
F Exercised Operated Day 7 5 8 4 76665 31.0908 4.441543 
F Exercised Operated Day 7 6 8 4 76665 31.0908 4.441543 
F Exercised Operated Day 7 7 8 4 76665 31.0908 4.441543 
F Exercised Operated Day 7 8 8 4 76665 31.0908 4.441543 
F Exercised Operated Day 28 1 6a 2 93005 26.88091 3.84013 
F Exercised Operated Day 28 2 6a 2 93005 26.88091 3.84013 
F Exercised Operated Day 28 3 22 2 93804 13.55592 1.93656 
F Exercised Operated Day 28 4 22 2 93804 13.55592 1.93656 
F Exercised Operated Day 28 5 8 4 76665 31.0908 4.441543 
F Exercised Operated Day 28 6 8 4 76665 31.0908 4.441543 
F Exercised Operated Day 28 7 8 4 76665 31.0908 4.441543 
F Exercised Operated Day 28 8 8 4 76665 31.0908 4.441543 
F Exercised Sham Day 7 1 7 4 146466.25 42.33263 3.527719 
F Exercised Sham Day 7 2 7 4 146466.25 42.33263 3.527719 
F Exercised Sham Day 7 3 7 4 146466.25 42.33263 3.527719 
F Exercised Sham Day 7 4 7 4 146466.25 42.33263 3.527719 
F Exercised Sham Day 7 5 2 4 209607.125 60.58202 3.786376 
F Exercised Sham Day 7 6 2 4 209607.125 60.58202 3.786376 
F Exercised Sham Day 7 7 2 4 209607.125 60.58202 3.786376 
F Exercised Sham Day 7 8 2 4 209607.125 60.58202 3.786376 
F Exercised Sham Day 28 1 7 4 146466.25 42.33263 3.527719 
F Exercised Sham Day 28 2 7 4 146466.25 42.33263 3.527719 
F Exercised Sham Day 28 3 7 4 146466.25 42.33263 3.527719 
F Exercised Sham Day 28 4 7 4 146466.25 42.33263 3.527719 
F Exercised Sham Day 28 5 2 4 209607.125 60.58202 3.786376 
F Exercised Sham Day 28 6 2 4 209607.125 60.58202 3.786376 
F Exercised Sham Day 28 7 2 4 209607.125 60.58202 3.786376 
F Exercised Sham Day 28 8 2 4 209607.125 60.58202 3.786376 
 
Balb/c Functional Vasodilation Data 
Sex Treatment Limb 
Time 
Point 
Replicate 
Cage 
# 
Resting 
(µm) 
Dilated 
(µm) 
Percent 
change (%) 
M Sedentary Operated Day 7 1 16 73.2 76.8 4.918033 
M Sedentary Operated Day 7 2 16 64.8 69.4 7.098765 
M Sedentary Operated Day 7 3 16 77.1 81.1 5.188067 
M Sedentary Operated Day 7 4 16 50.2 64.4 28.28685 
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M Sedentary Operated Day 7 5 14 64.8 68 4.938272 
M Sedentary Operated Day 7 6 15 56.9 59.7 4.920914 
M Sedentary Sham Day 7 1 16 21.6 32.5 50.46296 
M Sedentary Sham Day 7 2 16 33.3 48.3 45.04505 
M Sedentary Sham Day 7 3 16 47.5 68.8 44.84211 
M Sedentary Sham Day 7 4 16 20.9 46.6 122.9665 
M Sedentary Sham Day 7 5 14 38.1 53.4 40.15748 
M Sedentary Sham Day 7 6 15 36.5 56.7 55.34247 
M Exercised Operated Day 7 1 13 73.9 98.3 33.01759 
M Exercised Operated Day 7 2 13 56 69 23.21429 
M Exercised Operated Day 7 3 12 61.3 66.2 7.993475 
M Exercised Operated Day 7 4 12 58.7 70 19.25043 
M Exercised Operated Day 7 5 12 27.2 74.2 172.7941 
M Exercised Operated Day 7 6 12 38.8 54.3 39.94845 
M Exercised Sham Day 7 1 13 21.2 35 65.09434 
M Exercised Sham Day 7 2 13 29.2 39.5 35.27397 
M Exercised Sham Day 7 3 12 21.5 37.3 73.48837 
M Exercised Sham Day 7 4 12 30.8 42.2 37.01299 
M Exercised Sham Day 7 5 12 27.2 45.8 68.38235 
M Exercised Sham Day 7 6 12 29 47.5 63.7931 
 
Balb/c Exercise Data 
Sex Treatment Limb 
Time 
Point 
Replicate 
Cage 
# 
Mice 
per 
cage 
Total 
revolutions 
Total 
distance 
(km) 
Avg 
distance 
per day 
(km) 
M Exercised Operated Day 7 1 13 2 31333.5 9.056213 1.293745 
M Exercised Operated Day 7 2 13 2 31333.5 9.056213 1.293745 
M Exercised Operated Day 7 3 12 4 47035.75 13.59458 1.942083 
M Exercised Operated Day 7 4 12 4 47035.75 13.59458 1.942083 
M Exercised Operated Day 7 5 12 4 47035.75 13.59458 1.942083 
M Exercised Operated Day 7 6 12 4 47035.75 13.59458 1.942083 
M Exercised Sham Day 7 1 13 2 31333.5 9.056213 1.293745 
M Exercised Sham Day 7 2 13 2 31333.5 9.056213 1.293745 
M Exercised Sham Day 7 3 12 4 47035.75 13.59458 1.942083 
M Exercised Sham Day 7 4 12 4 47035.75 13.59458 1.942083 
M Exercised Sham Day 7 5 12 4 47035.75 13.59458 1.942083 
M Exercised Sham Day 7 6 12 4 47035.75 13.59458 1.942083 
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Reliability Measurements – Collateral Diameter (µm) 
 
 
Image Quality Error Measurements – Collateral Diameter (µm) 
  
Day Measurement Image 1 Image 2 Image 3 Image 4 Image 5 Image 6
1 1 33.3 21.4 54.1 27.3 99.8 33.4
1 2 37.5 28.5 60.2 28.9 105 29.9
1 3 35.3 30.4 56.1 28.9 106.4 39.9
2 1 34.6 28 58.1 27.2 98.4 31.5
2 2 30.1 28.5 56.3 28 97.1 34.3
2 3 36 28 55.4 28.9 100.1 36.2
Image Minimum Maximum Range
1 16.4 22.9 6.5
2 23.5 35.2 11.7
3 16.6 28 11.4
4 21.9 31.9 10
5 33.3 42.2 8.9
6 20.1 30.9 10.8
7 37.6 52.5 14.9
8 31.9 41.6 9.7
9 18.8 25.6 6.8
10 19.6 33.5 13.9
11 20.6 30.8 10.2
12 21.1 31.2 10.1
13 29.8 42.9 13.1
14 20.7 32.6 11.9
15 22.3 34.2 11.9
16 35.3 51.2 15.9
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Appendix D: Statistics 
Intraclass Correlation Coefficient (ICC) Calculation 
 
 
F = Fimage = 813.20 (from ANOVA above) 
𝑘 =
# 𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛𝑠 − # 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑚𝑒𝑛𝑡𝑠
# 𝑖𝑚𝑎𝑔𝑒𝑠 − 1
=
36 − 6
6 − 1
= 6 
𝐼𝐶𝐶 =
𝐹 − 1
𝐹 + 𝑘 − 1
=
813.20 − 1
813.20 + 6 − 1
= 0.99 
ICC = 0.99 
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Sample Paired T-Tests 
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Anderson Darling Normality Test [Resting Diameter] 
Strain Sex Treatment Limb Time Measurement AD p-value Normal? 
C57Bl/6 M Sedentary Operated Day 7 Resting Diameter 0.763 Yes 
C57Bl/6 M Sedentary Sham Day 7 Resting Diameter 0.095 Yes 
C57Bl/6 M Sedentary Operated Day 28 Resting Diameter 0.519 Yes 
C57Bl/6 M Sedentary Sham Day 28 Resting Diameter 0.356 Yes 
C57Bl/6 F Sedentary Operated Day 7 Resting Diameter 0.876 Yes 
C57Bl/6 F Sedentary Sham Day 7 Resting Diameter 0.094 Yes 
C57Bl/6 F Sedentary Operated Day 28 Resting Diameter 0.18 Yes 
C57Bl/6 F Sedentary Sham Day 28 Resting Diameter 0.285 Yes 
C57Bl/6 M Exercised Operated Day 7 Resting Diameter 0.719 Yes 
C57Bl/6 M Exercised Sham Day 7 Resting Diameter 0.749 Yes 
C57Bl/6 M Exercised Operated Day 28 Resting Diameter 0.053 Yes 
C57Bl/6 M Exercised Sham Day 28 Resting Diameter 0.393 Yes 
C57Bl/6 F Exercised Operated Day 7 Resting Diameter 0.425 Yes 
C57Bl/6 F Exercised Sham Day 7 Resting Diameter 0.558 Yes 
C57Bl/6 F Exercised Operated Day 28 Resting Diameter 0.007 No 
C57Bl/6 F Exercised Sham Day 28 Resting Diameter 0.221 Yes 
Balb/c M Sedentary Operated Day 7 Resting Diameter 0.782 Yes 
Balb/c M Sedentary Sham Day 7 Resting Diameter 0.489 Yes 
Balb/c M Exercised Operated Day 7 Resting Diameter 0.534 Yes 
Balb/c M Exercised Sham Day 7 Resting Diameter 0.131 Yes 
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Anderson Darling Normality Test [Dilated Diameter] 
Strain Sex Treatment Limb Time Measurement AD p-value Normal? 
C57Bl/6 M Sedentary Operated Day 7 Dilated Diameter 0.154 Yes 
C57Bl/6 M Sedentary Sham Day 7 Dilated Diameter 0.246 Yes 
C57Bl/6 M Sedentary Operated Day 28 Dilated Diameter 0.617 Yes 
C57Bl/6 M Sedentary Sham Day 28 Dilated Diameter 0.608 Yes 
C57Bl/6 F Sedentary Operated Day 7 Dilated Diameter 0.716 Yes 
C57Bl/6 F Sedentary Sham Day 7 Dilated Diameter 0.713 Yes 
C57Bl/6 F Sedentary Operated Day 28 Dilated Diameter 0.475 Yes 
C57Bl/6 F Sedentary Sham Day 28 Dilated Diameter 0.104 Yes 
C57Bl/6 M Exercised Operated Day 7 Dilated Diameter 0.657 Yes 
C57Bl/6 M Exercised Sham Day 7 Dilated Diameter 0.565 Yes 
C57Bl/6 M Exercised Operated Day 28 Dilated Diameter 0.57 Yes 
C57Bl/6 M Exercised Sham Day 28 Dilated Diameter 0.36 Yes 
C57Bl/6 F Exercised Operated Day 7 Dilated Diameter 0.891 Yes 
C57Bl/6 F Exercised Sham Day 7 Dilated Diameter 0.364 Yes 
C57Bl/6 F Exercised Operated Day 28 Dilated Diameter 0.04 No 
C57Bl/6 F Exercised Sham Day 28 Dilated Diameter 0.492 Yes 
Balb/c M Sedentary Operated Day 7 Dilated Diameter 0.834 Yes 
Balb/c M Sedentary Sham Day 7 Dilated Diameter 0.79 Yes 
Balb/c M Exercised Operated Day 7 Dilated Diameter 0.176 Yes 
Balb/c M Exercised Sham Day 7 Dilated Diameter 0.856 Yes 
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Anderson Darling Normality Test [Percent Change in Diameter] 
Strain Sex Treatment Limb Time Measurement AD p-value Normal? 
C57Bl/6 M Sedentary Operated Day 7 Percent Change 0.408 Yes 
C57Bl/6 M Sedentary Sham Day 7 Percent Change <0.005 No 
C57Bl/6 M Sedentary Operated Day 28 Percent Change 0.508 Yes 
C57Bl/6 M Sedentary Sham Day 28 Percent Change 0.073 Yes 
C57Bl/6 F Sedentary Operated Day 7 Percent Change 0.121 Yes 
C57Bl/6 F Sedentary Sham Day 7 Percent Change 0.418 Yes 
C57Bl/6 F Sedentary Operated Day 28 Percent Change 0.431 Yes 
C57Bl/6 F Sedentary Sham Day 28 Percent Change 0.201 Yes 
C57Bl/6 M Exercised Operated Day 7 Percent Change 0.374 Yes 
C57Bl/6 M Exercised Sham Day 7 Percent Change 0.384 Yes 
C57Bl/6 M Exercised Operated Day 28 Percent Change 0.771 Yes 
C57Bl/6 M Exercised Sham Day 28 Percent Change 0.551 Yes 
C57Bl/6 F Exercised Operated Day 7 Percent Change 0.022 No 
C57Bl/6 F Exercised Sham Day 7 Percent Change 0.442 Yes 
C57Bl/6 F Exercised Operated Day 28 Percent Change 0.102 Yes 
C57Bl/6 F Exercised Sham Day 28 Percent Change 0.872 Yes 
Balb/c M Sedentary Operated Day 7 Percent Change <0.005 No 
Balb/c M Sedentary Sham Day 7 Percent Change <0.005 No 
Balb/c M Exercised Operated Day 7 Percent Change <0.005 No 
Balb/c M Exercised Sham Day 7 Percent Change 0.065 Yes 
 
Sample Normal Probability Plots 
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F-Test for Equal Variance and ANOVA [Resting Diameter] 
Group 1 
Group 1 
normal? 
Group 2 
Group 2 
normal? 
F-Test 
p-value 
Equal 
variances? 
ANOVA 
p-value 
Different 
means? 
M_Sed_Op_d7 Yes M_Sed_Sh_d7 Yes 0.236 Yes 0 Yes 
F_Sed_Sh_d7 Yes M_Sed_Sh_d7 Yes 0.897 Yes 0.123 No 
F_Sed_Op_d7 Yes F_Sed_Sh_d7 Yes 0.158 Yes 0 Yes 
F_Sed_Op_d7 Yes M_Sed_Op_d7 Yes 0.73 Yes 0.673 No 
M_Sed_Sh_d28 Yes M_Sed_Sh_d7 Yes 0.795 Yes 0.101 No 
M_Sed_Op_d28 Yes M_Sed_Sh_d28 Yes 0.09 Yes 0.006 Yes 
M_Sed_Op_d28 Yes M_Sed_Op_d7 Yes 0.818 Yes 0.021 Yes 
F_Sed_Sh_d28 Yes M_Sed_Sh_d28 Yes 0.855 Yes 0.806 No 
F_Sed_Sh_d28 Yes F_Sed_Sh_d7 Yes 0.555 Yes 0.791 No 
F_Sed_Op_d28 Yes F_Sed_Sh_d28 Yes 0.992 Yes 0.845 No 
F_Sed_Op_d28 Yes M_Sed_Op_d28 Yes 0.047 No 0.006 Yes 
F_Sed_Op_d28 Yes F_Sed_Op_d7 Yes 0.038 No 0 Yes 
M_Ex_Sh_d7 Yes M_Sed_Sh_d7 Yes 0.916 Yes 0.07 No 
M_Ex_Op_d7 Yes M_Ex_Sh_d7 Yes 0.031 No 0.004 Yes 
M_Ex_Op_d7 Yes M_Sed_Op_d7 Yes 0.401 Yes 0.154 No 
F_Ex_Sh_d7 Yes M_Ex_Sh_d7 Yes 0.648 Yes 0.671 No 
F_Ex_Sh_d7 Yes F_Sed_Sh_d7 Yes 0.488 Yes 0.567 No 
F_Ex_Op_d7 Yes F_Ex_Sh_d7 Yes 0.026 No 0.052 No 
F_Ex_Op_d7 Yes M_Ex_Op_d7 Yes 0.706 Yes 0.113 No 
F_Ex_Op_d7 Yes F_Sed_Op_d7 Yes 0.919 Yes 0.01 Yes 
M_Ex_Sh_d28 Yes M_Ex_Sh_d7 Yes 0.155 Yes 0.476 No 
M_Ex_Sh_d28 Yes M_Sed_Sh_d28 Yes 0.217 Yes 0.31 No 
M_Ex_Op_d28 Yes M_Ex_Sh_d28 Yes 0.003 No 0.058 No 
M_Ex_Op_d28 Yes M_Ex_Op_d7 Yes 0.868 Yes 0.117 No 
M_Ex_Op_d28 Yes M_Sed_Op_d28 Yes 0.673 Yes 0.277 No 
F_Ex_Sh_d28 Yes M_Ex_Sh_d28 Yes 0.92 Yes 0.956 No 
F_Ex_Sh_d28 Yes F_Ex_Sh_d7 Yes 0.392 Yes 0.751 No 
F_Ex_Sh_d28 Yes F_Sed_Sh_d28 Yes 0.368 Yes 0.195 No 
B_Sed_Sh_d7 Yes M_Sed_Sh_d7 Yes 0.731 Yes 0.185 No 
B_Sed_Op_d7 Yes B_Sed_Sh_d7 Yes 0.953 Yes 0 Yes 
B_Sed_Op_d7 Yes M_Sed_Op_d7 Yes 0.368 Yes 0.178 No 
B_Ex_Sh_d7 Yes B_Sed_Sh_d7 Yes 0.068 Yes 0.18 No 
B_Ex_Sh_d7 Yes M_Ex_Sh_d7 Yes 0.132 Yes 0.204 No 
B_Ex_Op_d7 Yes B_Ex_Sh_d7 Yes 0.008 No 0.011 Yes 
B_Ex_Op_d7 Yes B_Sed_Op_d7 Yes 0.276 Yes 0.168 No 
B_Ex_Op_d7 Yes M_Ex_Op_d7 Yes 0.665 Yes 0.413 No 
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Levene’s Test for Equal Variance and Kruskal-Wallis [Resting Diameter] 
Group 1 
Group 1 
normal? 
Group 2 
Group 2 
normal? 
Levene 
Test 
p-value 
Equal 
variances? 
Kruskal-
Wallis 
p-value 
Different 
medians? 
F_Ex_Op_d28 No F_Ex_Sh_d28 Yes 0.391 Yes 0.007 Yes 
F_Ex_Op_d28 No M_Ex_Op_d28 Yes 0.523 Yes 0.958 No 
F_Ex_Op_d28 No F_Ex_Op_d7 Yes 0.334 Yes 1 No 
F_Ex_Op_d28 No F_Sed_Op_d28 Yes 0.466 Yes 0.059 No 
  
Comparison of C57Bl/6 Resting Diameter 
 
 
Comparison of Balb/c and C57Bl/6 Resting Diameter 
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F-Test for Equal Variance and ANOVA [Dilated Diameter] 
Group 1 
Group 1 
normal? 
Group 2 
Group 2 
normal? 
F-Test  
p-value 
Equal 
variances? 
ANOVA 
p-value 
Different 
means? 
M_Sed_Op_d7 Yes M_Sed_Sh_d7 Yes 0.976 Yes 0.002 Yes 
F_Sed_Sh_d7 Yes M_Sed_Sh_d7 Yes 0.574 Yes 0.063 No 
F_Sed_Op_d7 Yes F_Sed_Sh_d7 Yes 0.204 Yes 0 Yes 
F_Sed_Op_d7 Yes M_Sed_Op_d7 Yes 0.503 Yes 0.724 No 
M_Sed_Sh_d28 Yes M_Sed_Sh_d7 Yes 0.74 Yes 0.248 No 
M_Sed_Op_d28 Yes M_Sed_Sh_d28 Yes 0.498 Yes 0 Yes 
M_Sed_Op_d28 Yes M_Sed_Op_d7 Yes 0.752 Yes 0.572 No 
F_Sed_Sh_d28 Yes M_Sed_Sh_d28 Yes 0.929 Yes 0.622 No 
F_Sed_Sh_d28 Yes F_Sed_Sh_d7 Yes 0.893 Yes 0.193 No 
F_Sed_Op_d28 Yes F_Sed_Sh_d28 Yes 0.322 Yes 0.001 Yes 
F_Sed_Op_d28 Yes M_Sed_Op_d28 Yes 0.806 Yes 0.518 No 
F_Sed_Op_d28 Yes F_Sed_Op_d7 Yes 0.923 Yes 0.869 No 
M_Ex_Sh_d7 Yes M_Sed_Sh_d7 Yes 0.965 Yes 0.054 No 
M_Ex_Op_d7 Yes M_Ex_Sh_d7 Yes 0.263 Yes 0 Yes 
M_Ex_Op_d7 Yes M_Sed_Op_d7 Yes 0.235 Yes 0.852 No 
F_Ex_Sh_d7 Yes M_Ex_Sh_d7 Yes 0.038 No 0.401 No 
F_Ex_Sh_d7 Yes F_Sed_Sh_d7 Yes 0.137 Yes 0.646 No 
F_Ex_Op_d7 Yes F_Ex_Sh_d7 Yes 0.052 Yes 0 Yes 
F_Ex_Op_d7 Yes M_Ex_Op_d7 Yes 0.204 Yes 0.383 No 
F_Ex_Op_d7 Yes F_Sed_Op_d7 Yes 0.434 Yes 0.387 No 
M_Ex_Sh_d28 Yes M_Ex_Sh_d7 Yes 0.117 Yes 0.895 No 
M_Ex_Sh_d28 Yes M_Sed_Sh_d28 Yes 0.243 Yes 0.226 No 
M_Ex_Op_d28 Yes M_Ex_Sh_d28 Yes 0.018 Yes 0.001 Yes 
M_Ex_Op_d28 Yes M_Ex_Op_d7 Yes 0.891 Yes 0.62 No 
M_Ex_Op_d28 Yes M_Sed_Op_d28 Yes 0.48 Yes 0.242 No 
F_Ex_Sh_d28 Yes M_Ex_Sh_d28 Yes 0.957 Yes 0.62 No 
F_Ex_Sh_d28 Yes F_Ex_Sh_d7 Yes 0.71 Yes 0.109 No 
F_Ex_Sh_d28 Yes F_Sed_Sh_d28 Yes 0.288 Yes 0.049 → 0.05 No* 
B_Sed_Sh_d7 Yes M_Sed_Sh_d7 Yes 0.853 Yes 0.123 No 
B_Sed_Op_d7 Yes B_Sed_Sh_d7 Yes 0.376 Yes 0.009 Yes 
B_Sed_Op_d7 Yes M_Sed_Op_d7 Yes 0.425 Yes 0.015 Yes 
B_Ex_Sh_d7 Yes B_Sed_Sh_d7 Yes 0.069 Yes 0.093 No 
B_Ex_Sh_d7 Yes M_Ex_Sh_d7 Yes 0.077 Yes 0.137 No 
B_Ex_Op_d7 Yes B_Ex_Sh_d7 Yes 0.031 No 0.003 Yes 
B_Ex_Op_d7 Yes B_Sed_Op_d7 Yes 0.206 Yes 0.762 No 
B_Ex_Op_d7 Yes M_Ex_Op_d7 Yes 0.668 Yes 0.221 No 
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Levene’s Test for Equal Variance and Kruskal-Wallis [Dilated Diameter] 
Group 1 
Group 1 
normal? 
Group 2 
Group 2 
normal? 
Levene 
Test 
p-value 
Equal 
variances? 
Kruskal-
Wallis 
p-value 
Different 
medians? 
F_Ex_Op_d28 No F_Ex_Sh_d28 Yes 0.152 Yes 0.002 Yes 
F_Ex_Op_d28 No M_Ex_Op_d28 Yes 0.722 Yes 0.6 No 
F_Ex_Op_d28 No F_Ex_Op_d7 Yes 0.55 Yes 0.372 No 
F_Ex_Op_d28 No F_Sed_Op_d28 Yes 0.856 Yes 0.916 No 
 
Comparison of C57Bl/6 Dilated Diameter 
 
 
Comparison of Balb/c and C57Bl/6 Dilated Diameter 
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F-Test for Equal Variance and ANOVA [Percent Change in Diameter] 
Group 1 
Group 1 
normal? 
Group 2 
Group 2 
normal? 
F-Test  
p-value 
Equal 
variances? 
ANOVA 
p-value 
Different 
means? 
F_Sed_Op_d7 Yes F_Sed_Sh_d7 Yes 0.037 No 0.005 Yes 
F_Sed_Op_d7 Yes M_Sed_Op_d7 Yes 0.993 Yes 0.696 No 
M_Sed_Op_d28 Yes M_Sed_Sh_d28 Yes 0.687 Yes 0.866 No 
M_Sed_Op_d28 Yes M_Sed_Op_d7 Yes 0.001 No 0.01 Yes 
F_Sed_Sh_d28 Yes M_Sed_Sh_d28 Yes 0.308 Yes 0.824 No 
F_Sed_Sh_d28 Yes F_Sed_Sh_d7 Yes 0.106 Yes 0.515 No 
F_Sed_Op_d28 Yes F_Sed_Sh_d28 Yes 0.552 Yes 0.027 Yes 
F_Sed_Op_d28 Yes M_Sed_Op_d28 Yes 0.935 Yes 0.004 Yes 
F_Sed_Op_d28 Yes F_Sed_Op_d7 Yes 0.002 No 0 Yes 
M_Ex_Op_d7 Yes M_Ex_Sh_d7 Yes 0.222 Yes 0.336 No 
M_Ex_Op_d7 Yes M_Sed_Op_d7 Yes 0.009 No 0.054 No 
F_Ex_Sh_d7 Yes M_Ex_Sh_d7 Yes 0.225 Yes 0.087 No 
F_Ex_Sh_d7 Yes F_Sed_Sh_d7 Yes 0.716 Yes 0.25 No 
M_Ex_Sh_d28 Yes M_Ex_Sh_d7 Yes 0.2 Yes 0.242 No 
M_Ex_Sh_d28 Yes M_Sed_Sh_d28 Yes 0.852 Yes 0.953 No 
M_Ex_Op_d28 Yes M_Ex_Sh_d28 Yes 0.055 Yes 0.469 No 
M_Ex_Op_d28 Yes M_Ex_Op_d7 Yes 0.033 No 0.102 No 
M_Ex_Op_d28 Yes M_Sed_Op_d28 Yes 0.139 Yes 0.382 No 
F_Ex_Sh_d28 Yes M_Ex_Sh_d28 Yes 0.833 Yes 0.789 No 
F_Ex_Sh_d28 Yes F_Ex_Sh_d7 Yes 0.907 Yes 0.478 No 
F_Ex_Sh_d28 Yes F_Sed_Sh_d28 Yes 0.19 Yes 0.719 No 
F_Ex_Op_d28 Yes F_Ex_Sh_d28 Yes 0.618 Yes 0.246 No 
F_Ex_Op_d28 Yes M_Ex_Op_d28 Yes 0.078 Yes 0.857 No 
F_Ex_Op_d28 Yes F_Sed_Op_d28 Yes 0.697 Yes 0.026 Yes 
B_Ex_Sh_d7 Yes M_Ex_Sh_d7 Yes 0.63 Yes 0.927 No 
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Levene’s Test for Equal Variance and Kruskal-Wallis [Percent Change in Diameter] 
Group 1 
Group 1 
normal? 
Group 2 
Group 2 
normal? 
Levene 
Test 
p-value 
Equal 
variances? 
Kruskal-
Wallis 
p-value 
Different 
medians? 
B_Sed_Sh_d7 No M_Sed_Sh_d7 Yes 0.867 Yes 0.522 No 
B_Sed_Op_d7 No B_Sed_Sh_d7 No 0.35 Yes 0.004 Yes 
B_Sed_Op_d7 No M_Sed_Op_d7 Yes 0.306 Yes 0.239 No 
B_Ex_Sh_d7 Yes B_Sed_Sh_d7 No 0.728 Yes 0.749 No 
B_Ex_Op_d7 No B_Ex_Sh_d7 Yes 0.392 Yes 0.109 No 
B_Ex_Op_d7 No B_Sed_Op_d7 No 0.245 Yes 0.016 Yes 
B_Ex_Op_d7 No M_Ex_Op_d7 Yes 0.787 Yes 0.796 No 
 
Comparison of C57Bl/6 Percent Change in Diameter 
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Sample F-Tests for Equal Variances, Interval Plots, and Tukey or Games-Howell Comparisons of Means 
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Sample Regression Plots of Resting Diameter, Dilated Diameter, and % Change vs. Running Distance 
 
 
 
 
 
 
 
 
 
 
 
